These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38512035)

  • 1. [Yes-associated protein (YAP) promotes invasion and migration of cutaneous squamous cell carcinoma cells by activating the PI3K/AKT pathway].
    Li Z; Yang F; Jin X; Wang X; Chen T; Quan C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):244-251. PubMed ID: 38512035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Bowen disease to cutaneous squamous cell carcinoma: eight markers were verified from transcriptomic and proteomic analyses.
    Biao T; Cai-Feng H; Xiao-Hong L; Xiao-Li C; Wen-Bei L; Jun W; Chao C; Tao Y
    J Transl Med; 2022 Sep; 20(1):416. PubMed ID: 36085041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway.
    Lu D; Sun L; Li Z; Mu Z
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA LINC00520 prevents the progression of cutaneous squamous cell carcinoma through the inactivation of the PI3K/Akt signaling pathway by downregulating EGFR.
    Mei XL; Zhong S
    Chin Med J (Engl); 2019 Feb; 132(4):454-465. PubMed ID: 30707166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RBM3 Inhibits the Cell Cycle of Cutaneous Squamous Cell Carcinoma through the PI3K/AKT Signaling Pathway.
    Huang Y; Sun W; Zhu D; Liu L; Feng J; Yi Q
    Curr Mol Pharmacol; 2024; 17():e18761429323760. PubMed ID: 39041256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of kynureninase restrains cutaneous squamous cell carcinoma proliferation and represses the PI3K/AKT pathway.
    Ci C; Wu C; Lyu D; Chang X; He C; Liu W; Chen L; Ding W
    Clin Exp Dermatol; 2020 Mar; 45(2):194-201. PubMed ID: 31419330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of long noncoding RNA MALAT1 promotes the occurrence and progression of cutaneous squamous cell carcinoma].
    Li SS; Zhou L; Gao L; Wang YH; Ding ZH
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Apr; 38(4):421-427. PubMed ID: 29735442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transglutaminase 3 regulates cutaneous squamous carcinoma differentiation and inhibits progression via PI3K-AKT signaling pathway-mediated Keratin 14 degradation.
    Zhou K; Wu C; Cheng W; Zhang B; Wei R; Cheng D; Li Y; Cao Y; Zhang W; Yao Z; Zhang X
    Cell Death Dis; 2024 Apr; 15(4):252. PubMed ID: 38589352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TOPK Affects Autophagy of Skin Squamous Cell Carcinoma by Regulating NF-KB Pathway through HDAC1.
    Li J; Zhang ZC; Yuan XS; Tang SS; Wang T; Liu HF; Cao Y
    Dis Markers; 2022; 2022():3771711. PubMed ID: 35756488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artesunate restrains the malignant progression of human cutaneous squamous cell carcinoma cells via the suppression of the PI3K/AKT pathway.
    Huang X; Zhang S; Wang W
    Tissue Cell; 2022 Jun; 76():101789. PubMed ID: 35338984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. circ_0001821 Contributes to the Development of Cutaneous Squamous Cell Carcinoma by Regulating MicroRNA-148a-3p/EGFR Axis and Activating Phosphatidylinositol 3-Kinase/Akt Pathway.
    Zhang Z; Deng X
    Mol Cell Biol; 2022 Mar; 42(3):e0008921. PubMed ID: 35191745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-mesenchymal transition during invasion of cutaneous squamous cell carcinoma is paralleled by AKT activation.
    Barrette K; Van Kelst S; Wouters J; Marasigan V; Fieuws S; Agostinis P; van den Oord J; Garmyn M
    Br J Dermatol; 2014 Nov; 171(5):1014-21. PubMed ID: 24628329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yes-Associated Protein Contributes to the Development of Human Cutaneous Squamous Cell Carcinoma via Activation of RAS.
    Jia J; Li C; Luo S; Liu-Smith F; Yang J; Wang X; Wang N; Lai B; Lei T; Wang Q; Xiao S; Shao Y; Zheng Y
    J Invest Dermatol; 2016 Jun; 136(6):1267-1277. PubMed ID: 26902922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.
    Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD
    J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of miR1290 on the growth of endometrial cancer and the related mechanism].
    Shen XC; Sun YQ; Yan L; Zhao XX
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):130-138. PubMed ID: 35184456
    [No Abstract]   [Full Text] [Related]  

  • 17. Downregulation of HDAC3 by ginsenoside Rg3 inhibits epithelial-mesenchymal transition of cutaneous squamous cell carcinoma through c-Jun acetylation.
    Zhang L; Shan X; Chen Q; Xu D; Fan X; Yu M; Yan Q; Liu J
    J Cell Physiol; 2019 Dec; 234(12):22207-22219. PubMed ID: 31192452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
    Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of ARMC8 promotes tumorigenesis through activating Wnt/β-catenin pathway and EMT in cutaneous squamous cell carcinomas.
    Li X; Zhang C; Yuan Y; Wang Y; Lu S; Zhou Z; Zhen P; Zhou M
    J Dermatol Sci; 2021 Jun; 102(3):184-192. PubMed ID: 34016486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of Tyrosine Kinase Receptor 2 in Oral Squamous Cell Carcinoma and the Effect on Cell Proliferation and Migration and Epithelial-Mesenchymal Transition Process].
    Zheng M; Huang Y; Fei W; Shen Y; Nie X; Gao MY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):342-349. PubMed ID: 36949696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.